Back
Y-mAbs Therapeutics Stock Price Chart
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.
Sell
47
YMAB
Y-mAbs Therapeutics
Last Price:
$4.71
Seasonality Move:
7.09%
7 Day Trial
ALL ACCESS PASS
$
7
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.-
The current trend is moderately bullish and YMAB is experiencing slight buying pressure.
Y-mAbs Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.97 | Sell |
| 20-day SMA: | 4.64 | Buy |
| 50-day SMA: | 4.44 | Buy |
| 200-day SMA: | 8.53 | Sell |
| 8-day EMA: | 4.85 | Sell |
| 20-day EMA: | 4.7 | Buy |
| 50-day EMA: | 4.7 | Buy |
| 200-day EMA: | 7.27 | Sell |
Y-mAbs Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 51.75 | Buy |
| Chaikin Money Flow: | 90060 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.06 - 4.94) | Buy |
| Bollinger Bands (100): | (4.23 - 5.73) | Sell |
Y-mAbs Therapeutics Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Y-mAbs Therapeutics Stock
Is Y-mAbs Therapeutics Stock a Buy?
-
Y-mAbs Therapeutics share price is 4.71 while YMAB 8-day simple moving average is 4.97, which is a Sell signal.
-
The stock price of YMAB is 4.71 while Y-mAbs Therapeutics 20-day SMA is 4.64, which makes it a Buy.
-
Y-mAbs Therapeutics 50-day simple moving average is 4.44 while YMAB share price is 4.71, making it a Buy technically.
-
YMAB stock price is 4.71 and Y-mAbs Therapeutics 200-day simple moving average is 8.53, creating a Sell signal.
YMAB Technical Analysis vs Fundamental Analysis
Sell
47
Y-mAbs Therapeutics (YMAB)
is a Sell
Is Y-mAbs Therapeutics a Buy or a Sell?
-
Y-mAbs Therapeutics stock is rated a SellThe current Y-mAbs Therapeutics [YMAB] share price is $4.71. The Score for YMAB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Y-mAbs Therapeutics Stock Info
Market Cap:
213.3M
Price in USD:
4.71
Share Volume:
472.8K
Y-mAbs Therapeutics 52-Week Range
52-Week High:
16.11
52-Week Low:
3.55
Sell
47
Y-mAbs Therapeutics (YMAB)
is a Sell
Y-mAbs Therapeutics Share Price Forecast
-
What is the Y-mAbs Therapeutics stock price today?The Y-mAbs Therapeutics stock price is 4.71 USD today.
-
Will YMAB stock go up or go down?Y-mAbs Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Y-mAbs Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Y-mAbs Therapeutics is overvalued.
Is Y-mAbs Therapeutics Stock a Buy?
-
Y-mAbs Therapeutics share price is 4.71 while YMAB 8-day exponential moving average is 4.85, which is a Sell signal.
-
The stock price of YMAB is 4.71 while Y-mAbs Therapeutics 20-day EMA is 4.70, which makes it a Buy.
-
Y-mAbs Therapeutics 50-day exponential moving average is 4.70 while YMAB share price is 4.71, making it a Buy technically.
-
YMAB stock price is 4.71 and Y-mAbs Therapeutics 200-day simple moving average is 7.27, creating a Sell signal.
Fundamental Analysis of Y-mAbs Therapeutics
Is Y-mAbs Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.09 per share.
Technical Analysis of Y-mAbs Therapeutics
Should I short Y-mAbs Therapeutics stock?
-
YMAB Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting Y-mAbs Therapeutics is a Buy
-
Y-mAbs Therapeutics Relative Strength Index (RSI) is 51.75, which suggest Y-mAbs Therapeutics is overbought
-
The Bollinger Bands (25) for Y-mAbs Therapeutics is (4.06 - 4.94), which suggest Y-mAbs Therapeutics is a Sell
-
The Bollinger Bands (100) for Y-mAbs Therapeutics is (4.23 - 5.73), which suggest Y-mAbs Therapeutics is a Sell
* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.